Introduction
We previously synthesized N-mercaptoalkanoyl derivatives of sulfur-containing amino acids, and reported that compound 8, having benzyl at the R' position, ethyl at the R2 position and hydrogen at the R3 and R4 positions in Fig. 1 , was a rather potent inhibitor of angiotensin I converting enzyme (ACE)." As part of an effort to develop active ACE inhibitors, we synthesized additional N-mercaptoalkanoyl derivatives of sulfur-containing amino acids. We examined the effects of these compounds, which showed potent ACEinhibitory action in vitro, on the pressor responses to angiotensin I (Al) and the depressor responses to bradykinin (BK) in anesthetized rats.
Chemistry
Compounds listed in Table I were prepared by standard techniques (Chart 1). 3-(Acylthio)-2-alkylpropanoic acids (1, 2) , prepared by Michael addition of thiobenzoic acid to a-alkylacrylic acids obtained by the method of Mannich and Ganz,2) were treated with SOC12 to give the corresponding acid chlorides (3) , which were condensed with S-ethyl-L-cysteine (4) to give the corresponding N-(acylthio)alkanoylamino acids (6, 7) . Removal of the benzoyl group of 7b-k was carried out with aqueous ammonia to give the corresponding N- mercaptoalkanoyl-S-ethyl-L-cysteines (5b k).
The (tetrahydrofuryl)thio compound (9) was obtained by addition of the mercapto compound (8) to 2,3-dihydrofuran in the presence of p-toluenesulfonic acid. N-[3-(Substituted benzoylthio)-2-benzylpropanoyl]-S-ethyl-L-cysteines (10, 11) were prepared by reaction of 8 with the corresponding substituted benzoyl chlorides. Compounds 12 and 13 listed in Table  III were prepared by condensation of 5d with N-benzoyl-D-amino acids in the presence of N,N'-carbonyldiimidazole.
Biological Results and Discussion
In Vitro ACE Inhibitory Activity
We evaluated the in vitro ACE-inhibitory activities of the synthesized N-mercaptoalkanoyl derivatives of sulfur-containing amino acids; the IC50 values are summarized in Table I .
As regards the length of methylene chain in the phenylalkyl moiety at the R1 position, Chart 1 CH2 (compound 8) resulted in higher activity than (CH2)2 (compound 5b) or (CH2)3 (compound Sc). The activities of 5b and Sc were 1/3 and 1/20 of that of 8, respectively. Compounds having a p-methoxybenzyl (5d), p-methoxyphenethyl (5e), p-ethoxybenzyl (5f), pchlorobenzyl (5g) or m,p-dimethoxybenzyl (Si) group at the R1 position showed the same inhibitory action as 8 in vitro. However, introduction of a p-methyl (5h) or an o-methoxy (5j) group into the benzyl moiety of compound 8 led to a decrease of activity. Compound 5k, having a cyclopentyl group at the R1 position, showed little potency. We previously reported that compounds having hydrogen at the R3 position showed potent inhibitory action towards ACE, but alkylation at this position caused complete loss of the inhibitory activity. To investigate the effects of replacement of the R3 moiety with substituents other than alkyl, a number of derivatives were prepared. The ACE-inhibitory activity of the compound possessing a benzoyl (7a) or tetrahydrofuryl (9) group was almost equal to that of compound 8, whereas replacement of the hydrogen with an acetyl (6a), oacetoxybenzoyl (10) or p-methoxybenzoyl (11) group lowered the activity.
In Vivo ACE-Inhibitory Action Table II shows the in vivo results obtained with selected ACE inhibitors. Compound 5d, which was the most potent ACE inhibitor among the compounds tested in the present study, caused a significant reduction (26 mmHg) of arterial blood pressure in anesthetized rats. The arterial blood pressure level returned to the control level within 10 min after administration. On the other hand, the hypotensive action of captopril reached the maximum at 1 to 3 min after administration and lasted for at least 1 h. The injection of compound 5d resulted in inhibition of the pressor responses to Al and potentiation of the depressor responses to BK, although these actions of the compound were of short duration compared with those induced by captopril.
It was reported that the introduction of a cyclohexanecarbonyl-D-alany13) or benzoyl-Dphenylalany14) group into the sulfhydryl moiety of captopril augments the duration of ACEinhibitory action. Based on these findings, we synthesized compounds 12 and 13 which contain these groups in the sulfhydryl moiety of 5d. However, these compounds were less potent than 5d in terms of both ACE-inhibitory activity in vitro (Table III) and hypotensive action in vivo. 
